Novozymes A/S provided earnings guidance for the year 2023. For the year, the company expects a solid organic sales growth at 4% to 7% driven by pricing as well as volume growth.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
423.8 DKK | +1.69% | -1.42% | +13.99% |
06-18 | Transcript : Novozymes A/S - Analyst/Investor Day | |
06-18 | European shares advance ahead of inflation data, more c.bank speakers | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.99% | 28.38B | |
-25.86% | 3.26B | |
+8.40% | 1.76B | |
-23.78% | 543M | |
-34.05% | 353M | |
-81.65% | 216M | |
-10.04% | 115M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novozymes A/S Provides Earnings Guidance for the Year 2023